TR201819077T4 - İn-Vivo Hücrelerin Yok Edilmesi İçin Yüksek Yoğunluğa Sahip İnorganik Nanopartiküller - Google Patents

İn-Vivo Hücrelerin Yok Edilmesi İçin Yüksek Yoğunluğa Sahip İnorganik Nanopartiküller Download PDF

Info

Publication number
TR201819077T4
TR201819077T4 TR2018/19077T TR201819077T TR201819077T4 TR 201819077 T4 TR201819077 T4 TR 201819077T4 TR 2018/19077 T TR2018/19077 T TR 2018/19077T TR 201819077 T TR201819077 T TR 201819077T TR 201819077 T4 TR201819077 T4 TR 201819077T4
Authority
TR
Turkey
Prior art keywords
particles
vivo
destruction
relates
high density
Prior art date
Application number
TR2018/19077T
Other languages
English (en)
Inventor
Levy Laurent
Pottier Agnès
Rouet Annabelle
Marill Julie
Devaux Corinne
Germain Matthieu
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of TR201819077T4 publication Critical patent/TR201819077T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Abstract

Mevcut buluş, sağlık sektöründe kullanılabilen yenilikçi uyarılabilir partiküllerle ilgilidir. Daha belirgin olarak, X Işınları ve/veya elektron huzmeleri gibi iyonize edici radyasyonlar tarafından uyarıldığında, elektronları ve/veya yüksek enerji fotonlarını üretebilen partiküllerle ve özellikle insan sağlığında olmak üzere, sağlıkta bunların kullanımları ile ilgilidir. Yenilikçi partiküller, söz konusu maddenin yeterli bir yoğunluğa sahip olduğu oksijeni içeren inorganik bir maddeden oluşturulmaktadır ve hedef hücrelerin, dokuların veya organların rahatsız edilmesi, değiştirilmesi veya yok edilmesi için kontrol edilebilir harici uyarım ile canlı dışı, ex vivo veya in vivo olarak aktif hale getirilebilir. Buluş ayrıca, söz konusu partiküllerin üretimi için olan yöntemlerle ilgilidir ve aynısını içeren farmasötik bileşimler ile ilgilidir.
TR2018/19077T 2008-06-05 2009-06-04 İn-Vivo Hücrelerin Yok Edilmesi İçin Yüksek Yoğunluğa Sahip İnorganik Nanopartiküller TR201819077T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (en) 2008-06-05 2008-06-05 Inorganic nanoparticles of high density to destroy cells in-vivo
US6020208P 2008-06-10 2008-06-10

Publications (1)

Publication Number Publication Date
TR201819077T4 true TR201819077T4 (tr) 2019-01-21

Family

ID=39734334

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19077T TR201819077T4 (tr) 2008-06-05 2009-06-04 İn-Vivo Hücrelerin Yok Edilmesi İçin Yüksek Yoğunluğa Sahip İnorganik Nanopartiküller

Country Status (26)

Country Link
US (1) US8845507B2 (tr)
EP (4) EP2130553A1 (tr)
JP (1) JP5734181B2 (tr)
KR (1) KR101639281B1 (tr)
CN (1) CN102056628B (tr)
AU (1) AU2009254550B2 (tr)
BR (1) BRPI0913410B1 (tr)
CA (1) CA2727576C (tr)
CY (2) CY1118217T1 (tr)
DK (2) DK2300054T3 (tr)
EA (1) EA023012B1 (tr)
ES (2) ES2702249T3 (tr)
HR (2) HRP20161465T8 (tr)
HU (2) HUE040247T2 (tr)
IL (1) IL209625A (tr)
LT (2) LT3150227T (tr)
MA (1) MA32453B1 (tr)
MX (1) MX2010013322A (tr)
NZ (1) NZ589888A (tr)
PL (2) PL2300054T3 (tr)
PT (2) PT2300054T (tr)
SG (1) SG10201405288WA (tr)
SI (2) SI3150227T1 (tr)
TR (1) TR201819077T4 (tr)
WO (1) WO2009147214A2 (tr)
ZA (1) ZA201100082B (tr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075975A2 (en) * 2003-02-24 2004-09-10 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
WO2011060033A1 (en) * 2009-11-10 2011-05-19 Immunolight, L.L.C. Up and down coversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversion
JP6178725B2 (ja) 2010-04-23 2017-08-09 ピクセリジェント・テクノロジーズ，エルエルシー ナノ結晶の合成、キャップ形成および分散
US8920675B2 (en) 2010-10-27 2014-12-30 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
PL2790682T3 (pl) 2011-12-16 2019-08-30 Nanobiotix Nanocząstki zawierające materiał metaliczny i materiał tlenku hafnu, ich wytwarzanie i zastosowanie
EP2877212A4 (en) * 2012-06-14 2016-04-27 Univ Arkansas COMPOSITIONS AND METHODS FOR NON-INVASIVE DETECTION AND TREATMENT OF IN VIVO HYPOXIC CELLS
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
SG11201505277VA (en) * 2013-01-25 2015-08-28 Nanobiotix Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
RU2015135133A (ru) * 2013-02-19 2017-03-24 Нэшенел Хелс Рисёч Инститьютс Заключенные в оболочку нанокластеры платины для противораковых химиотерапевтических средств
EA038671B1 (ru) 2013-05-30 2021-10-01 Кюрадигм Сас Способ повышения терапевтической или профилактической эффективности представляющего интерес фармацевтического соединения
MX2015017774A (es) * 2013-06-20 2016-03-31 Nanobiotix Composiciones y metodos para el uso en el diagnostico medico.
EP2886128A1 (en) * 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
WO2016083331A1 (en) 2014-11-25 2016-06-02 Nanobiotix Pharmaceutical composition, preparation and uses thereof
NZ769187A (en) 2014-11-25 2023-07-28 Curadigm Sas Pharmaceutical composition, preparation and uses thereof
FI3229776T3 (fi) 2014-11-25 2023-08-15 Curadigm Sas Farmaseuttinen koostumus, joka yhdistää ainakin kaksi erillistä nanopartikkelia ja farmaseuttisen yhdisteen, sen valmistus ja käytöt
BR112017010933A2 (pt) 2014-11-25 2018-02-14 Nanobiotix composição farmacêutica
HUE056175T2 (hu) 2014-11-25 2022-01-28 Curadigm Sas Gyógyászati készítmények, elõállításuk és alkalmazásaik
EP3721887A1 (en) * 2015-01-08 2020-10-14 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
NZ738527A (en) * 2015-05-28 2022-07-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
US20230211175A1 (en) * 2020-05-26 2023-07-06 Nanobiotix S.A. Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof
AU2021374754A1 (en) * 2020-11-05 2023-06-22 Nanobiotix Compositions of nanoparticles for treatment of cancer
CN116615269A (zh) * 2020-12-01 2023-08-18 纳米生物技术公司 作为辐射增强剂的多孔、高z和无碳颗粒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
US20070274909A1 (en) 2003-12-17 2007-11-29 Koninklijke Philips Electronic, N.V. Radiation Therapy and Medical Imaging Using Uv Emitting Nanoparticles
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
JP2009544584A (ja) * 2006-07-10 2009-12-17 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 治療及び画像化を目的とするコア・シェル構造ナノ粒子
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging

Also Published As

Publication number Publication date
SI3150227T1 (sl) 2019-02-28
MX2010013322A (es) 2011-01-21
HUE030669T2 (en) 2017-05-29
NZ589888A (en) 2012-06-29
EP2300054B1 (en) 2016-09-07
DK2300054T3 (en) 2016-12-05
CA2727576C (en) 2016-08-16
JP2011524866A (ja) 2011-09-08
HRP20161465T1 (hr) 2017-01-27
IL209625A0 (en) 2011-02-28
ES2602048T3 (es) 2017-02-17
DK3150227T3 (en) 2019-01-14
EP2130553A1 (en) 2009-12-09
SI2300054T1 (sl) 2017-02-28
CN102056628A (zh) 2011-05-11
ES2702249T3 (es) 2019-02-28
CY1121078T1 (el) 2019-12-11
EA023012B1 (ru) 2016-04-29
LT2300054T (lt) 2016-12-27
WO2009147214A2 (en) 2009-12-10
MA32453B1 (fr) 2011-07-03
WO2009147214A3 (en) 2010-02-25
EP3150227A1 (en) 2017-04-05
PL3150227T3 (pl) 2019-05-31
IL209625A (en) 2015-11-30
EP3150227B1 (en) 2018-10-31
ZA201100082B (en) 2011-10-26
EP2300054A2 (en) 2011-03-30
AU2009254550B2 (en) 2013-10-24
HRP20181993T1 (hr) 2019-01-25
HRP20161465T8 (hr) 2017-04-21
PT3150227T (pt) 2018-12-24
KR101639281B1 (ko) 2016-07-13
BRPI0913410B1 (pt) 2021-09-21
PL2300054T3 (pl) 2017-04-28
HUE040247T2 (hu) 2019-02-28
JP5734181B2 (ja) 2015-06-17
AU2009254550A1 (en) 2009-12-10
US8845507B2 (en) 2014-09-30
CA2727576A1 (en) 2009-12-10
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
KR20110028616A (ko) 2011-03-21
CN102056628B (zh) 2013-07-10
CY1118217T1 (el) 2017-06-28
US20110213192A1 (en) 2011-09-01
EA201071429A1 (ru) 2011-06-30
SG10201405288WA (en) 2014-10-30
EP3461502A1 (en) 2019-04-03
BRPI0913410A2 (pt) 2015-11-24

Similar Documents

Publication Publication Date Title
TR201819077T4 (tr) İn-Vivo Hücrelerin Yok Edilmesi İçin Yüksek Yoğunluğa Sahip İnorganik Nanopartiküller
Li et al. Piezoelectric materials as sonodynamic sensitizers to safely ablate tumors: a case study using black phosphorus
Delben et al. Effect of atmospheric-pressure cold plasma on pathogenic oral biofilms and in vitro reconstituted oral epithelium
Benayas et al. PbS/CdS/ZnS quantum dots: a multifunctional platform for in vivo near‐infrared low‐dose fluorescence imaging
Samberg et al. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro
FR2869803B1 (fr) Particules activables, preparation et utilisations
Wang et al. Defect-related luminescent hydroxyapatite-enhanced osteogenic differentiation of bone mesenchymal stem cells via an ATP-induced cAMP/PKA pathway
Xiang et al. A multifunctional nanoplatform for lysosome targeted delivery of nitric oxide and photothermal therapy under 808 nm near-infrared light
Nakamura et al. Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT
Badea et al. Cisplatin loaded multiwalled carbon nanotubes induce resistance in triple negative breast cancer cells
MX2012000285A (es) Nanoparticulas metalicas, preparacion y uso de las mismas.
CY1113819T1 (el) Σκευασματα για τη θεραπευτικη αντιμετωπιση του καρκινου
DE502006004409D1 (de) Vorrichtung zur röntgen-tomosynthese
Kumar et al. Silver and gold doped hydroxyapatite nanocomposites for enhanced bone regeneration
BR112013003658A2 (pt) compostos antivirais contendo azida
Sisin et al. Evaluation of bismuth oxide nanoparticles as radiosensitizer for megavoltage radiotherapy
Dhawan et al. Toxicity assessment of engineered nanomaterials: resolving the challenges
Shimoyama et al. Access to a novel near-infrared photodynamic therapy through the combined use of 5-aminolevulinic acid and lanthanide nanoparticles
Ku et al. Lattice strain engineering of Ti3C2 narrows band gap for realizing extraordinary sonocatalytic bacterial killing
Orsi et al. New CeF3–ZnO nanocomposites for self-lighted photodynamic therapy that block adenocarcinoma cell life cycle
Stewart An investigation into the tailoring of bismuth oxide nanoceramic with a biomedical application as a high Z radiation enhancer for cancer therapy
Cherian et al. Evaluation of toxicity of maura reduced graphene oxide using in vitro systems
Vaja et al. Cytotoxic effects of ZnO nanoparticles incorporated in mesoporous silica
Wang et al. New perspective of ceria nanodots for precise tumor therapy via oxidative stress pathway
JP2016164099A (ja) 二酸化塩素発生装置および方法